HIV seroreversion time in HIV-1-uninfected children born to HIV-1-infected mothers in Malawi

Journal of Acquired Immune Deficiency Syndromes

Volumn 46, Issue 3, 2007, Pages 332-337

  Gulia, Jyoti ^a,b   Kumwenda, Newton ^a   Li, Qing ^a   Taha, Taha E ^a,c  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b WASHINGTON HOSPITAL CENTER   (United States)

^c NONE   (United States)

Author keywords

Antibodies; HIV AIDS; Mother to child transmission; Serology; Seroreversion

Indexed keywords

NEVIRAPINE; ZIDOVUDINE;

ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; COMBINATION CHEMOTHERAPY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INFANT; MAJOR CLINICAL STUDY; MALAWI; MALE; MOTHER; PRIORITY JOURNAL; SEROCONVERSION; SINGLE DRUG DOSE;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTIVIRAL AGENTS; DISEASE PROGRESSION; DISEASE TRANSMISSION, VERTICAL; FEMALE; HIV INFECTIONS; HIV SEROPOSITIVITY; HIV-1; HUMANS; INFANT; INFANT, NEWBORN; MALAWI; MALE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; TIME FACTORS;

EID: 37349063739     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3181576860     Document Type: Article

References (21)

1. Centers for Disease Control and Prevention. Classification system for human immunodeficiency virus (HIV) infection in children under 13 years of age. MMWR Morb Mortal Wkly Rep. 1987;36:225-230, 235-236.
2. Centers for Disease Control and Prevention. 1994 revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR Morb Mortal Wkly Rep. 1994;43:1-10.
3. Simpson BJ, Andiman WA. Difficulties in assigning human immunodeficiency virus-1 infection and seroreversion status in a cohort of HIV-exposed in children using serologic criteria established by the Centers for Disease Control and Prevention. Pediatrics. 1994;93:840-842.
4. Levin BR, Bull JJ, Stewart FM. Epidemiology, evolution, and future of the HIV/AIDS pandemic. Emerg Infect Dis. 2001;7(3 Suppl):505-511.
5. European Collaborative Study. Risk factors for mother-to-child transmission of HIV-1. Lancet. 1992;339:1007-1012.
6. Chantry CJ, Cooper ER, Pelton SI, et al. Seroreversion in human immunodeficiency virus-exposed but uninfected infants. Pediatr Infect Dis J. 1995;14:382-387.
7. Andiman WA, Simpson BJ, Olson B, et al. Rate of transmission of human immunodeficiency virus type 1 infection from mother to child and short-term outcome of neonatal infection. Results of a prospective cohort study. Am J Dis Child. 1990;144:758-766.
8. Taha TE, Dallabetta GA, Hoover DR, et al. Trends of HIV-1 and sexually transmitted diseases among pregnant and postpartum women in urban Malawi. AIDS. 1998;12:197-203.
9. Miotti PG, Dallabetta GA, Chiphangwi JD, et al. A retrospective study of childhood mortality and spontaneous abortion in HIV-1 infected women in urban Malawi. Int J Epidemiol. 1992;21:792-799.
10. Miotti PG, Dallabetta G, Ndovi E, et al. HIV-1 and pregnant women: associated factors, prevalence, estimate of incidence and role in fetal wastage in central Africa. AIDS. 1990;4:733-736.
11. Biggar RJ, Miotti PG, Taha TE, et al. Perinatal intervention trial in Africa: effect of a birth canal cleansing intervention to prevent HIV transmission. Lancet. 1996;347:1647-1650.
12. Miotti PG, Taha TE, Kumwenda NI, et al. HIV transmission through breastfeeding: a study in Malawi. JAMA. 1999;282:744-749.
13. Taha TE, Kumwenda NI, Gibbons A, et al. Short postexposure prophylaxis in newborn babies to reduce mother-to-child transmission of HIV-1: NVAZ randomised clinical trial. Lancet. 2003;362:1171-1177.
14. Taha TE, Kumwenda NI, Hoover DR, et al. Nevirapine and zidovudine at birth to reduce perinatal transmission of HIV in an African setting: a randomized controlled trial. JAMA. 2004;292:202-209.
15. Centers for Disease Control and Prevention. 2000. CDC Growth Charts for the United States: Methods and Development. Series report 11, No. 246. Available at: http://www.cdc.gov/growthcharts. Accessed March 5, 2007.
16. World Health Organization. Interim WHO clinical staging of HIV/AIDS and HIV/AIDS case definitions for surveillance: African region. 2005. Available at: http://www.who.int/hiv/pub/guidelines/casedefinitions/en/. Accessed March 5, 2007.
17. Maldonado YA, Lawrence EC, DeHovitz R, et al. Early loss of passive measles antibody in infants of mothers with vaccine-induced immunity. Pediatrics. 1995;96:447-450.
18. Szenborn L, Tischer A, Pejcz J, et al. Passive acquired immunity against measles in infants born to naturally infected and vaccinated mothers. Med Sci Monit. 2003;9:CR541-CR546.
19. Kollmann TR, Rubinstein A, Lyman WD, et al. Characterization of IgG and IgG subclass antibodies present in paired maternal and fetal serum which are directed against HIV-1 proteins. AIDS Res Hum Retroviruses. 1991;7:847-854.
20. Kameda T, Koyama M, Matsuzaki N, et al. Localization of three subtypes of Fc-gamma receptors in human placenta by immunohistochemical analysis. Placenta. 1991;12:15-26.
21. McNabb T, Koh TY, Dorrington KJ, et al. Structure and function of immunoglobulin domains: V. Binding of immunoglobulin G and fragments to placental membrane preparations. J Immunol. 1976;117:882-888.